Collegium Pharmaceutical Inc - ESG Rating & Company Profile powered by AI
The webpage displays a free ESG report for Collegium Pharmaceutical Inc. This ESG score covers seventeen UN SDGs including: 'Quality Education', 'Decent Work & Economic Growth' and 'Life below Water'. If you are employed by Collegium Pharmaceutical Inc and you would like to use your Sustainability aseessment, please get in touch.
Collegium Pharmaceutical Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 3.2 and governance score of 3.2.
2.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | Collegium Pharmaceutical Inc | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Collegium Pharmaceutical Inc have an accelerator or VC vehicle to help deliver innovation?
Does Collegium Pharmaceutical Inc disclose current and historical energy intensity?
Does Collegium Pharmaceutical Inc report the average age of the workforce?
Does Collegium Pharmaceutical Inc reference operational or capital allocation in relation to climate change?
Does Collegium Pharmaceutical Inc disclose its ethnicity pay gap?
Does Collegium Pharmaceutical Inc disclose cybersecurity risks?
Does Collegium Pharmaceutical Inc offer flexible work?
Does Collegium Pharmaceutical Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Collegium Pharmaceutical Inc disclose the number of employees in R&D functions?
Does Collegium Pharmaceutical Inc conduct supply chain audits?
Does Collegium Pharmaceutical Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Collegium Pharmaceutical Inc conduct 360 degree staff reviews?
Does Collegium Pharmaceutical Inc disclose the individual responsible for D&I?
Does Collegium Pharmaceutical Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Collegium Pharmaceutical Inc disclose current and / or historical scope 2 emissions?
Does Collegium Pharmaceutical Inc disclose water use targets?
Does Collegium Pharmaceutical Inc have careers partnerships with academic institutions?
Did Collegium Pharmaceutical Inc have a product recall in the last two years?
Does Collegium Pharmaceutical Inc disclose incidents of discrimination?
Does Collegium Pharmaceutical Inc allow for Work Councils/Collective Agreements to be formed?
Has Collegium Pharmaceutical Inc issued a profit warning in the past 24 months?
Does Collegium Pharmaceutical Inc disclose parental leave metrics?
Does Collegium Pharmaceutical Inc disclose climate scenario or pathway analysis?
Does Collegium Pharmaceutical Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Collegium Pharmaceutical Inc disclose the pay ratio of women to men?
Does Collegium Pharmaceutical Inc support suppliers with sustainability related research and development?
Does Collegium Pharmaceutical Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Collegium Pharmaceutical Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Collegium Pharmaceutical Inc involved in embryonic stem cell research?
Does Collegium Pharmaceutical Inc disclose GHG and Air Emissions intensity?
Does Collegium Pharmaceutical Inc disclose its waste policy?
Does Collegium Pharmaceutical Inc report according to TCFD requirements?
Does Collegium Pharmaceutical Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Collegium Pharmaceutical Inc disclose energy use targets?
Does Collegium Pharmaceutical Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Collegium Pharmaceutical Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Collegium Pharmaceutical Inc
These potential risks are based on the size, segment and geographies of the company.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.